Stay updated with breaking news from Virus Encephalitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
According to Aidar Ishmukhametov, the center filed an application with the WHO for CoviVac’s assessment and its subsequent inclusion in the EUL in April 2021
Earlier, the Russian health ministry issued a license for the third phase of CoviVac clinical tests in children
6 May in 12:40 Russia’s Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences has proved the efficacy of its polio vaccine against the novel coronavirus, the Center’s director, Aidar Ishmukhametov, said. "We inoculated volunteers with a live polio vaccine and observed a dramatic slump in [coronavirus] incidence in this group. We have proved that," he said in an interview with the Vesti daily news roundup on the Rossiya-1 television channel. "So far, we have left aside this matter [the efficacy of a polio vacc...
According to Aidar Ishmukhametov, the study involved more than 600 people in the city of Kirov © Vyacheslav Prokofyev/TASS MOSCOW, May 6. /TASS/. Russia’s Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences has proved the efficacy of its polio vaccine against the novel coronavirus, the Center’s director, Aidar Ishmukhametov, said on Wednesday. "We inoculated volunteers with a live polio vaccine and observed a dramatic slump in [coronavirus] incidence in this group. We have proved that," he said in an inte...
The Chumakov Center’s inactivated whole-virion Covivac vaccine was registered with the Russian health ministry on February 19